Physician profile
Shivraj Singh
NPI 1376434886
$4,050.57
in general payments reported to CMS, 2019-2025
6 companies · $4,051 in 2025
The $4,051 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,485 · Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,484.81 |
| Food and Beverage | $1,565.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,458.84 | 2025 | Evoke |
| Boston Scientific Corporation | $1,343.65 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 | |
| Collegium Pharmaceutical, INC. | $67.22 | 2025 | Belbuca, Xtampza |
| Tonix Medicines, INC. | $32.94 | 2025 | Tonmya |
| Averitas Pharma INC. | $22.93 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivraj Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.